Results 231 to 240 of about 1,322,023 (308)

Establishment of pediatric reference ranges for circulating naïve and memory T and B cell subsets guided by the human immunophenotyping consortium standardization initiative: A large, single center U.S. experience

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Our knowledge of the immune system continues to expand at a rapid pace, and this coupled with technological advances now enables us to interrogate both the breadth and the depth of the immune response at levels without precedent. This has also facilitated rapidly integrating some of this carefully vetted knowledge into clinical practice ...
Aaruni Khanolkar, Aisha Ahmed
wiley   +1 more source

Challenges and Opportunities of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus Control and Elimination Policies, Regulations, and Strategies in Ethiopia. [PDF]

Health Sci Rep
Dagnaw M, Geremew BM, Gezie LD.
europepmc   +1 more source

A practical difference from the normal approach to evaluate natural killer (NK) cells and NK cell neoplasms by flow cytometry

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Natural killer (NK) cell neoplasms span indolent to highly aggressive entities, and flow cytometric immunophenotyping is central to their detection and classification. However, distinguishing reactive from neoplastic NK cell expansions can be challenging because NK cells lack somatically recombined antigen receptors, and reactive states may ...
Aaron J. Wilk, Afshin Shameli, Erik Ames, Jonathan R. Fromm, Bartosz Grzywacz, Min Shi, Sindhu Cherian, Jean Oak   +7 more
wiley   +1 more source

HIV Returns

American Journal of Public Health, 2003
openaire   +3 more sources

Burden, patterns, and challenges of HIV-associated malignancies in Nigeria: a narrative review. [PDF]

Front Oncol
Silas O, Nyam C, Tsok Y, Eshioramine M, Nnaegbuna N, Golit W, Okunowo A, Osuagwu C, Offor J, Achusi I, Beneye T, Isikhuemen M, Ekanem V, Ekpe L, Odusolu P, Akinjo A, TAGCReC, Rasheed F, Ayoade F, Audu B, Saad A, Omotoso A, George S.   +22 more
europepmc   +1 more source

Eating Disorders in Transgender, Non‐Binary, and Gender Diverse Populations: A Meta‐Synthesis of Qualitative Findings

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Some evidence suggests that gender diverse people may be disproportionately affected by eating disorders in comparison to the general population. This review aims to further understanding of the relationship between gender identity and disordered eating/exercise, as understood by gender diverse individuals.
Kirsty Matthews, Kai S. Thomas, John R. E. Fox, Falguni Nathwani, Marc O. Williams   +4 more
wiley   +1 more source

A scoping review of pre-exposure prophylaxis awareness, acceptability, uptake, adherence, and HIV-related risk behaviors among university students in South Africa. [PDF]

Front Public Health
Serebane MJ, Ramavhoya TI, Mutshatshi TE, Mokhwelepa LW.   +3 more
europepmc   +1 more source

Proportion, Five‐Year Survival Rate of Laryngeal Cancer and Its Associated Factors Among Head and Neck Cancer Patients in Tanzania

Eye &ENT Research, EarlyView.
ABSTRACT Background Laryngeal cancer carries a significant global burden, with substantial morbidity and mortality, and is increasing globally, with 95%–98% being squamous cell carcinoma. Males are more affected than females, with peak cases occurring between 60 and 80 years of age.
Amenye Adili, Furaha Serventi, Baraka M. Musimu, Mica Magembe, Orest Tarimo, Geofrey Ikelesho, Salum Kalonge, Leonard Kiboko, Queen Godfrey Tarimo, Desderius C. Chussi   +9 more
wiley   +1 more source

Digital interventions supporting health and social reintegration after incarceration, including HIV-related stigma and care continuity: a scoping review protocol. [PDF]

BMJ Open
Pule LM, Mabena KME, Smuts H, Seretlo RJ, Mokgatle MM.   +4 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source